{
    "eid": "2-s2.0-85046022382",
    "title": "Could Alzheimer\u2019s Disease Originate in the Periphery and If So How So?",
    "cover-date": "2019-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Cellular and Molecular Neuroscience",
            "@code": "2804",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "Alzheimer\u2019s disease",
        "Gene expression",
        "Inflammation",
        "Microglia",
        "Mitochondria",
        "Molecular neurobiology"
    ],
    "authors": [
        "Gerwyn Morris",
        "Michael Berk",
        "Michael Maes",
        "Basant K. Puri"
    ],
    "citedby-count": 44,
    "ref-count": 392,
    "ref-list": [
        "Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer\u2019s disease",
        "Intracellular amyloid-\u03b2 in Alzheimer\u2019s disease",
        "Pathways towards and away from Alzheimer\u2019s disease",
        "Amyloid precursor protein processing and Alzheimer\u2019s disease",
        "APP processing in Alzheimer\u2019s disease",
        "The role of APP and BACE1 trafficking in APP processing and amyloid-\u03b2 generation",
        "AICD nuclear signaling and its possible contribution to Alzheimers disease",
        "Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer\u2019s disease",
        "Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer\u2019s disease",
        "Metal dyshomeostasis and oxidative stress in Alzheimer\u2019s disease",
        "GSK-3\u00ce2, a pivotal kinase in Alzheimer disease",
        "Alzheimer\u2019s disease and amyloid: Culprit or coincidence?",
        "Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: a retrospective study",
        "The putative use of lithium in Alzheimer\u2019s disease",
        "Oxidative stress and the pathogenesis of Alzheimer\u2019s disease",
        "The oxidative stress hypothesis in Alzheimer\u2019s disease",
        "The Alzheimer\u2019s disease mitochondrial cascade hypothesis",
        "Mitochondrial dysfunction is a trigger of Alzheimer\u2019s disease pathophysiology",
        "An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory",
        "Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer\u2019s disease",
        "The roles of inflammation and immune mechanisms in Alzheimer\u2019s disease",
        "Autophagy and Alzheimer\u2019s disease",
        "Autophagy in Alzheimer\u2019s disease",
        "Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer\u2019s disease",
        "The ubiquitin-proteasome system: Potential therapeutic targets for Alzheimer\u2019s disease and spinal cord injury",
        "Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD",
        "Oxidative stress in Alzheimer\u2019s disease: why did antioxidant therapy fail?",
        "Protein phosphatase 2A dysfunction in Alzheimer\u2019s disease",
        "Oxidative inhibition of protein phosphatase 2A activity: role of catalytic subunit disulfides",
        "Alzheimer\u2019s disease causation by copper toxicity and treatment with zinc",
        "The role of zinc in Alzheimer\u2019s disease",
        "Iron neurochemistry in Alzheimer\u2019s disease and Parkinson\u2019s disease: targets for therapeutics",
        "Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer\u2019s disease",
        "Differential phenotypes of myeloid-derived suppressor and T regulatory cells and cytokine levels in amnestic mild cognitive impairment subjects compared to mild Alzheimer diseased patients",
        "The Trojan horse\u2014neuroinflammatory impact of T cells in neurodegenerative diseases",
        "A meta-analysis of cytokines in Alzheimer\u2019s disease",
        "Gut microbiome alterations in Alzheimer\u2019s disease",
        "Microbiome-derived lipopolysaccharide enriched in the perinuclear region of Alzheimer\u2019s disease brain",
        "Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies",
        "How does brain insulin resistance develop in Alzheimer\u2019s disease?",
        "Inflammation, cytokines and insulin resistance: a clinical perspective",
        "Mitochondrial dysfunction and insulin resistance: an update",
        "Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease",
        "Oxidative stress and insulin resistance: the Coronary Artery Risk Development in Young Adults study",
        "Aging of the T cell compartment in mice and humans: from no na\u00efve expectations to foggy memories",
        "Aging in down syndrome and the development of Alzheimer\u2019s disease neuropathology",
        "GSK3 as a sensor determining cell fate in the brain",
        "Autophagy and aging",
        "Brain tau deposition linked to systemic causes of death in normal elderly",
        "Determinants of iron accumulation in the normal aging brain",
        "Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction",
        "Peripheral inflammation and cognitive aging",
        "T cell recruitment in the brain during normal aging",
        "Biomarkers of Alzheimer disease in plasma",
        "Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease",
        "Involvement of ApoE E4 and H63D in sporadic Alzheimer\u2019s disease in a folate-supplemented Ontario population",
        "HFE gene variants, iron, and lipids: a novel connection in Alzheimer\u2019s disease",
        "TREM2 and neurodegenerative disease",
        "Soluble TREM2 induces inflammatory responses and enhances microglial survival",
        "ANK1 is up-regulated in laser captured microglia in Alzheimer\u2019s brain; the importance of addressing cellular heterogeneity",
        "Epigenetic alterations in Alzheimer\u2019s disease",
        "Alzheimer\u2019s disease: analyzing the missing heritability",
        "Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer's disease brain",
        "Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease",
        "Alzheimer&#39;s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci",
        "Epigenetic signature and enhancer activity of the human APOE gene",
        "The APOE gene is differentially methylated in Alzheimer\u2019s disease",
        "TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer\u2019s disease hippocampus",
        "Peripheral inflammatory markers in Alzheimer\u2019s disease: A systematic review and meta-analysis of 175 studies",
        "At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response",
        "Systemic inflammation and disease progression in Alzheimer disease",
        "Corrigendum to \u201cPeripherally administrated prions reach the brain at sub-infectious quantities in experimental hamsters\u201d [FEBS Lett. 588 (2014) 795-800]",
        "Vitamin B12 levels in Alzheimer\u2019s disease: association with clinical features and cytokine production",
        "Proinflammatory cytokines, sickness behavior, and Alzheimer disease",
        "Association between cytokine production and disease severity in Alzheimer\u2019s disease",
        "Combinatorial markers of MCI conversion: cytokines and MRI measures together predict disease progression",
        "Combinatorial markers of mild cognitive impairment conversion to Alzheimer\u2019s disease\u2014cytokines and MRI measures together predict disease progression",
        "T-cells in Alzheimer\u2019s disease",
        "Lymphocytes in Alzheimer&#39;s disease",
        "Immune profiling of Alzheimer patients",
        "Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer\u2019s disease",
        "Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer\u2019s disease",
        "Insights on the pathophysiology of Alzheimer\u2019s disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system",
        "Lymphocytes in Alzheimer\u2019s disease pathology: altered signaling pathways",
        "T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer\u2019s disease-like cerebral amyloidosis",
        "Alterations in the peripheral immune system in dementia",
        "Linking T cells to Alzheimer\u2019s disease: from neurodegeneration to neurorepair",
        "Increased levels of antigen-bound \u03b2-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer\u2019s disease patients",
        "Increased number of plasma B cells producing autoantibodies against Abeta42 protofibrils in Alzheimer\u2019s disease",
        "Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer\u2019s disease and normal controls",
        "Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide",
        "Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease",
        "Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer\u2019s disease and control subjects",
        "The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimmune processes with an emphasis on inflammatory bowel disease type 1 diabetes and chronic fatigue syndrome",
        "The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease",
        "Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide",
        "The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization",
        "Enhanced B-cell activation mediated by TLR4 and BCR crosstalk",
        "Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation",
        "TLR4 ligands lipopolysaccharide and monophosphoryl lipid a differentially regulate effector and memory CD8+ T cell differentiation",
        "Lipopolysaccharide potentiates effector T cell accumulation into non-lymphoid tissues through TRIF",
        "Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex",
        "Direct recognition of LPS drive TLR4 expressing CD8(+) T cell activation in patients with rheumatoid arthritis",
        "Lipopolysaccharide induces IFN-\u03b3 production in human NK cells",
        "Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10",
        "Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer\u2019s disease",
        "The role of natural killer cells in Alzheimer\u2019s disease",
        "Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression",
        "Implications of apolipoprotein E genotype on inflammation and vitamin E status",
        "Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress",
        "Clearance of dying cells by phagocytes: mechanisms and implications for disease pathogenesis",
        "Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses",
        "Intestinal commensal microbes as immune modulators",
        "Gut microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis",
        "Influences of the gut microbiota on DNA methylation and histone modification",
        "Adaptive immunity against gut microbiota enhances apoE-mediated immune regulation and reduces atherosclerosis and western-diet-related inflammation",
        "MiR-155 is involved in Alzheimer\u2019s disease by regulating T lymphocyte function",
        "Common DNA methylation alterations of Alzheimer\u2019s disease and aging in peripheral whole blood",
        "Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer\u2019s disease (AD) and in primary human neuronal-glial (HNG) cells",
        "The functional analysis of microRNAs involved in NF-kappaB signaling",
        "Expression profiling of LPS responsive miRNA in primary human macrophages",
        "Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity",
        "Influence of apolipoprotein E isoform on microRNA transcriptome in macrophages",
        "Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b",
        "MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response",
        "An NF-\u03baB-microRNA regulatory network tunes macrophage inflammatory responses",
        "Up-regulation of miRNA-146a in progressive, age-related inflammatory neurodegenerative disorders of the human CNS",
        "TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells",
        "Increased TREM-2 expression on the subsets of CD11c+ cells in the lungs and lymph nodes during allergic airway inflammation",
        "The triggering receptor expressed on myeloid cells 2 binds apolipoprotein E",
        "DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer\u2019s disease",
        "TREM2 mRNA expression in leukocytes is increased in Alzheimer\u2019s disease and schizophrenia",
        "Higher peripheral TREM2 mRNA levels relate to cognitive deficits and hippocampal atrophy in Alzheimer\u2019s disease and amnestic mild cognitive impairment",
        "Study of protein phosphatase 2A (PP2A) activity in LPS-induced tolerance using fluorescence-based and immunoprecipitation-aided methodology",
        "Protein phosphatase 2A in lipopolysaccharide-induced cyclooxygenase-2 expression in murine lymphatic endothelial cells",
        "Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses",
        "Cell death pathways: A novel therapeutic approach for neuroscientists",
        "Microglial pathology",
        "Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer\u2019s disease",
        "Microglia function in Alzheimer\u2019s disease",
        "Microglia actions in Alzheimer\u2019s disease",
        "Microglia receptors and their implications in the response to amyloid \u03b2 for Alzheimer\u2019s disease pathogenesis",
        "Systemic infections and inflammation affect chronic neurodegeneration",
        "Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease",
        "Microglial priming and Alzheimer\u2019s disease: a possible role for (early) immune challenges and epigenetics?",
        "The innate immune system in Alzheimer\u2019s disease",
        "TREM2 variants in Alzheimer\u2019s disease",
        "TREM2 protein expression changes correlate with Alzheimer\u2019s disease neurodegenerative pathologies in post-mortem temporal cortices",
        "TREM2 and the neuroimmunology of Alzheimer\u2019s disease",
        "What happens to microglial TREM2 in Alzheimer\u2019s disease: immunoregulatory turned into immunopathogenic?",
        "TREM2 in neurodegenerative diseases",
        "The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases",
        "Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia",
        "DAP12 stabilizes the C-terminal fragment of the triggering receptor expressed on myeloid cells-2 (TREM2) and protects against LPS-induced pro-inflammatory response",
        "Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease",
        "TREM2/DAP12 complex regulates inflammatory responses in microglia via the JNK signaling pathway",
        "TREM2/DAP12 signal elicits proinflammatory response in microglia and exacerbates neuropathic pain",
        "Sequential proteolytic processing of the triggering receptor expressed on myeloid Cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage",
        "The epigenome in Alzheimer\u2019s disease: current state and approaches for a new path to gene discovery and understanding disease mechanism",
        "The cytoskeleton adaptor protein ankyrin-1 is upregulated by p53 following DNA damage and alters cell migration",
        "MicroRNA-486-3p regulates gamma-globin expression in human erythroid cells by directly modulating BCL11A",
        "ANK1 methylation regulates expression of microRNA-486-5p and discriminates lung tumors by histology and smoking status",
        "Circulating plasma microRNAs can differentiate human sepsis and systemic inflammatory response syndrome (SIRS)",
        "Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer",
        "MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc",
        "Low frequency magnetic fields induce autophagy-associated cell death in lung cancer through miR-486-mediated inhibition of Akt/mTOR signaling pathway",
        "Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation",
        "Akt signaling pathway in macrophage activation and M1/M2 polarization",
        "Differential pro-inflammatory responses of astrocytes and microglia involve STAT3 activation in response to 1800 MHz radiofrequency fields",
        "Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology",
        "Stat3 signaling referees microglial amyloid clearance in Alzheimer\u2019s disease. Alzheimer\u2019s Dement",
        "TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease",
        "Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer\u2019s disease",
        "Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease",
        "Clearance of cerebral A\u03b2 in Alzheimer\u2019s disease: reassessing the role of microglia and monocytes",
        "TLR2 is a primary receptor for Alzheimer\u2019s amyloid peptide to trigger neuroinflammatory activation",
        "Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease",
        "Astrocytes in Alzheimer\u2019s disease",
        "Astroglia in dementia and Alzheimer\u2019s disease",
        "Astrocytes: regulation of brain homeostasis via apolipoprotein E",
        "Apolipoprotein E controls cerebrovascular integrity via cyclophilin a",
        "Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer\u2019s disease",
        "Astrocytes contain amyloid-\u03b2 annular protofibrils in Alzheimer\u2019s disease brains",
        "The contribution of activated astrocytes to A\u03b2 production: implications for Alzheimer\u2019s disease pathogenesis",
        "Calcium-sensing receptors of human astrocyte-neuron teams: amyloid-\u03b2-driven mediators and therapeutic targets of Alzheimer\u2019s disease",
        "Causal link between oxidative stress, inflammation, and hypertension",
        "The toll-like receptor radical cycle pathway: a new drug target in immune-related chronic fatigue",
        "Metals, oxidative stress and neurodegenerative disorders",
        "Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity",
        "Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment",
        "Oxidative damage, protein synthesis, and protein degradation in Alzheimers disease",
        "Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer\u2019s disease",
        "Oxidative stress promotes JNK-dependent amyloidogenic processing of normally expressed human APP by differential modification of \u03b1-, \u03b2- and \u03b3-secretase expression",
        "Oxidative stress activates a positive feedback between the \u03b3- and \u03b2-secretase cleavages of the \u03b2-amyloid precursor protein",
        "Hydrogen peroxide promotes A\u03b2 production through JNK-dependent activation of \u03b3-secretase",
        "Gene structure and organization of the human -secretase (BACE) promoter",
        "Expression of APP pathway mRNAs and proteins in Alzheimer\u2019s disease",
        "Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease",
        "Amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w",
        "Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative Tauopathies?",
        "The ambiguous relationship of oxidative stress, tau hyperphosphorylation, and autophagy dysfunction in Alzheimer\u2019s disease",
        "A\u03b2 and tau toxicities in Alzheimer\u2019s are linked via oxidative stress-induced p38 activation: protective role of vitamin E",
        "Oxidative regulation of fatty acid-induced tau polymerization\u2020",
        "Activation of P38 kinase links \u03c0 phosphorylation, oxidative stress and cell cycle-related events in Alzheimer disease",
        "F2-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo",
        "Oxidative insults are associated with apolipoprotein E genotype in Alzheimer\u2019s disease brain",
        "Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue",
        "Apolipoprotein E genotype and oxidative stress in peripheral lymphocytes of patients with Alzheimer\u2019s disease",
        "Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease",
        "The key role of mitochondria in Alzheimer\u2019s disease",
        "Mitochondrial a: A potential focal point for neuronal metabolic dysfunction in Alzheimer\u2019s disease",
        "Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease",
        "Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease",
        "Mitochondrial dysfunction in Alzheimer\u2019s disease and the rationale for bioenergetics based therapies",
        "Mitochondrial dysfunction\u2014the beginning of the end in Alzheimer\u2019s disease? Separate and synergistic modes of tau and amyloid-\u03b2 toxicity",
        "Clinical features and pathogenesis of Alzheimer\u2019s disease: Involvement of mitochondria and mitochondrial DNA",
        "Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide",
        "Is Alzheimer\u2019s disease a systemic disease?",
        "Mitochondrial dysfunction and immune activation are detectable in early Alzheimer\u2019s disease blood",
        "Peripheral mitochondrial dysfunction in Alzheimer\u2019s disease: focus on lymphocytes",
        "Nitrosative stress, hypernitrosylation, and autoimmune responses to nitrosylated proteins: New pathways in neuroprogressive disorders including depression and chronic fatigue syndrome",
        "Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS)",
        "Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways",
        "The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases",
        "Abnormalities of mitochondrial enzymes in Alzheimer disease",
        "Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer\u2019s disease",
        "TOMM40 and APOE gene expression and cognitive decline in Japanese Alzheimer\u2019s disease subjects",
        "The TOMM40 gene rs2075650 polymorphism contributes to Alzheimer\u2019s disease in Caucasian, and Asian populations",
        "The broad impact of TOM40 on neurodegenerative diseases in aging",
        "Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies",
        "Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease",
        "Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer\u2019s susceptibility gene",
        "18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons",
        "Mitochondrial dysfunction and synaptic transmission failure in Alzheimer\u2019s disease",
        "Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus",
        "Regional brain glucose hypometabolism in young women with polycystic ovary syndrome: possible link to mild insulin resistance",
        "Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes",
        "Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease",
        "Synaptic mitochondrial pathology in Alzheimer\u2019s disease",
        "Mitochondrial aspects of synaptic dysfunction in Alzheimer\u2019s disease",
        "Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS)",
        "The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling: new drug targets in neuroimmune disorders",
        "Dysfunction of the fusion of pre-synaptic plasma membranes and synaptic vesicles caused by oxidative stress, and its prevention by vitamin E",
        "Influence of oxidative stress on fusion of pre-synaptic plasma membranes of the rat brain with phosphatidyl choline liposomes, and protective effect of vitamin E",
        "Selective neuronal vulnerability to oxidative stress in the brain",
        "Alzheimer\u2019s disease: targeting the cholinergic system",
        "Impact of oxidative - nitrosative stress on cholinergic presynaptic function",
        "Impacts of oxidative stress on acetylcholinesterase transcription, and activity in embryos of zebrafish (Danio rerio) following chlorpyrifos exposure",
        "Oxidative stress biomarkers and acetylcholinesterase activity in human erythrocytes exposed to clomazone (in vitro)",
        "Oxidative stress in neurodegenerative diseases",
        "Diazoxide pretreatment prevents Abeta1-42 induced oxidative stress in cholinergic neurons via alleviating NOX2 expression",
        "Dysfunction of NMDA receptors in Alzheimer's disease",
        "Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: Relevance to schizophrenia",
        "The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders",
        "Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia",
        "Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer\u2019s disease",
        "Tau positron emission tomography using [18F]THK5351 and cerebral glucose hypometabolism in Alzheimer\u2019s disease",
        "Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer\u2019s disease dementia",
        "Impact of tau and amyloid burden on glucose metabolism in Alzheimer\u2019s disease",
        "Targeting glycogen synthase kinase-3\u03b2 for therapeutic benefit against oxidative stress in Alzheimer\u2019s disease: involvement of the Nrf2-ARE pathway",
        "Roles of glycogen synthase kinase 3 in Alzheimer\u2019s disease",
        "A model of the mitochondrial basis of bipolar disorder",
        "A pivotal role of GSK-3 in synaptic plasticity",
        "The GSK3 hypothesis of Alzheimer\u2019s disease",
        "Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses",
        "Increased level of active GSK-3? In Alzheimer\u2019s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration",
        "Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain",
        "Distribution of active glycogen synthase kinase 3\u03b2 (GSK-3\u03b2) in brains staged for Alzheimer disease neurofibrillary changes",
        "Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3\u03b2 and cyclin-dependent kinase 5, a component of TPK II",
        "Glycogen synthase kinase-3 is increased in white cells early in Alzheimer\u2019s disease",
        "Association between glycogen synthase kinase-3\u03b2 genetic polymorphism and late-onset Alzheimer\u2019s disease",
        "GSK3\u03b1 exhibits \u03b2-catenin and tau directed kinase activities that are modulated by Wnt",
        "Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules",
        "Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100",
        "GSK-3\u03b1 regulates production of Alzheimer\u2019s disease amyloid-\u03b2 peptides",
        "Neuroinflammatory phenotype in early Alzheimer\u2019s disease",
        "Sporadic and familial cerebral amyloid angiopathies",
        "Proteolytic processing of Alzheimer\u2019s beta-amyloid precursor protein",
        "ApoE4 increases glycogen synthase kinase 3beta expression and tau phosphorylation in U87 cells",
        "Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta",
        "Metabolic control by target of rapamycin and autophagy during ageing\u2014a mini-review",
        "Autophagy pathway: Cellular and molecular mechanisms",
        "The ubiquitin-proteasome system in Alzheimer\u2019s disease",
        "The decrease of Uch-L1 activity is a common mechanism responsible for A\u03b2 42 accumulation in Alzheimer\u2019s and vascular disease",
        "Autophagic/lysosomal dysfunction in Alzheimer\u2019s disease",
        "Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer\u2019s disease",
        "Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer\u2019s disease",
        "Immunoproteasome and LMP2 polymorphism in aged and Alzheimer\u2019s disease brains",
        "Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson\u2019s and Alzheimer\u2019s diseases",
        "mTOR\u2019s role in ageing: protein synthesis or autophagy?",
        "mTOR signaling at a glance",
        "mTOR signaling in growth control and disease",
        "Taking aim at Alzheimer\u2019s disease through the mammalian target of rapamycin",
        "Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer\u2019s disease",
        "PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer\u2019s disease",
        "mTOR and autophagy in normal brain aging and caloric restriction ameliorating age-related cognition deficits",
        "mTOR-dependent cell proliferation in the brain",
        "Dysfunction of the mTOR pathway is a risk factor for Alzheimer\u2019s disease",
        "mTOR: at the crossroads of aging, chaperones, and Alzheimer\u2019s disease",
        "Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-\u03b2, and tau",
        "Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis",
        "The relationship among mTOR, beta-amyloid and tau: therapeutic implications for Alzheimer\u2019s disease",
        "Molecular interplay between mTOR, A\u03b2 and tau: effects on cognitive impairments",
        "mTOR controls mitochondrial oxidative function through a YY1\u2013PGC-1\u03b1 transcriptional complex",
        "Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells",
        "Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signaling pathways in H4IIE hepatoma cells through inhibition of Ras",
        "The proteasome and the degradation of oxidized proteins: part II\u2014protein oxidation and proteasomal degradation",
        "Oxidative stress-mediated regulation of proteasome complexes",
        "Degradation of oxidized proteins by the 20S proteasome",
        "Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion",
        "The proteasome-interacting Ecm29 protein disassembles the 26S proteasome in response to oxidative stress",
        "Dopamine-modified \u03b1-synuclein blocks chaperone-mediated autophagy",
        "Disruption of chaperone-mediated autophagy-dependent degradation of MEF2A by oxidative stress-induced lysosome destabilization",
        "The influence of oxidation of membrane thiol groups on lysosomal proton permeability",
        "Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death",
        "Lysosomal membrane damage in soluble A\u03b2-mediated cell death in Alzheimer\u2019s disease",
        "In vivo quantitative susceptibility mapping (QSM) in Alzheimer\u2019s disease",
        "Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease",
        "Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2\u2019 mapping",
        "Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment",
        "Hepcidin and iron homeostasis",
        "Iron and hepcidin: a story of recycling and balance",
        "Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3)",
        "IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin",
        "STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo",
        "STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation",
        "Interleukin-6 induces hepcidin expression through STAT3",
        "Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells",
        "The blood-brain barrier: an engineering perspective",
        "Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-alpha and TGF-beta1",
        "Lipopolysaccharides upregulate hepcidin in neuron via microglia and the IL-6/STAT3 signaling pathway",
        "An overview of molecular basis of iron metabolism regulation and the associated pathologies",
        "The role of iron regulatory proteins in mammalian iron homeostasis and disease",
        "Endogenous interferon-beta-inducible gene expression and interferon-beta-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis",
        "Novel roles for iron regulatory proteins in the adaptive response to iron deficiency",
        "Modulation of cellular iron metabolism by hydrogen peroxide. Effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts",
        "Rapid responses to oxidative stress mediated by iron regulatory protein",
        "Peroxynitrite and nitric oxide differently target the iron-sulfur cluster and amino acid residues of human iron regulatory protein 1",
        "Nitric oxide and peroxynitrite activate the iron regulatory protein-1 of J774A.1 macrophages by direct disassembly of the Fe-S cluster of cytoplasmic aconitase",
        "Nitric oxide-mediated modulation of iron regulatory proteins: Implication for cellular iron homeostasis",
        "Iron regulatory protein-independent regulation of ferritin synthesis by nitrogen monoxide",
        "Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer\u2019s diseased brains",
        "Iron toxicity in diseases of aging: Alzheimer\u2019s disease, Parkinson\u2019s disease and atherosclerosis",
        "Variations in the APP gene promoter region and risk of Alzheimer disease",
        "Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases",
        "Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1",
        "Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease",
        "Iron levels modulate \u03b1-secretase cleavage of amyloid precursor protein",
        "A potential pathogenetic role of iron in Alzheimer\u2019s disease",
        "Furin is an endogenous regulator of alpha-secretase associated APP processing",
        "The role of iron in brain ageing and neurodegenerative disorders",
        "Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer\u2019s disease peptide -amyloid (1-42)",
        "Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer\u2019s disease peptide beta-amyloid",
        "Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer\u2019s disease peptide beta-amyloid (1-42)",
        "Iron biochemistry is correlated with amyloid plaque morphology in an established mouse model of Alzheimer\u2019s disease",
        "Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain",
        "Miller LM Synchrotron-based imaging detects metal and plaques in a mouse model of Alzheimer\u2019s disease",
        "Redox-active iron mediates amyloid-\u03b2 toxicity",
        "Metal ions differentially influence the aggregation and deposition of Alzheimer\u2019s \u03b2-amyloid on a solid template\u2020",
        "Proliferation of amyloid-beta42 aggregates occurs through a secondary nucleation mechanism",
        "Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer\u2019s Abeta peptides",
        "Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation",
        "A delicate balance: iron metabolism and diseases of the brain",
        "Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer\u2019s disease",
        "Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3",
        "Dietary and genetically-induced oxidative stress alter tau phosphorylation: influence of folate and apolipoprotein E deficiency",
        "Effect of iron on the activation of the MAPK/ERK pathway in PC12 neuroblastoma cells",
        "Deferoxamine synergistically enhances iron-mediated AP-1 activation: a showcase of the interplay between extracellular-signal-regulated kinase and tyrosine phosphatase",
        "Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain",
        "Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment",
        "Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice",
        "Heme oxygenase in neuroprotection: from mechanisms to therapeutic implications",
        "Atypical inflammation in the central nervous system in prion disease",
        "The role of metallothionein in oxidative stress",
        "Roles of metallothionein in copper homeostasis: responses to cu-deficient diets in mice",
        "Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer\u2019s and Parkinson\u2019s diseases",
        "PP2A inactivation by ROS accumulation",
        "Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway",
        "Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam",
        "The blood-brain barrier in Alzheimer\u2019s disease",
        "Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction?",
        "Imaging of leukocyte trafficking in Alzheimer\u2019s disease",
        "The blood-brain barrier endothelium: a target for pro-inflammatory cytokines",
        "The blood-brain barrier in systemic inflammation",
        "Striatal blood\u2013brain barrier permeability in Parkinson\u2019s disease",
        "Astrocytic modulation of blood brain barrier: perspectives on Parkinson\u2019s disease",
        "Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis",
        "Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target",
        "Environmental risk factors for Parkinson\u2019s disease and parkinsonism: the Geoparkinson study",
        "Epidemiology and causes of Parkinson\u2019s disease"
    ],
    "affiliation": [
        {
            "affiliation-city": "Melbourne",
            "@id": "60026553",
            "affilname": "University of Melbourne",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "London",
            "@id": "60020416",
            "affilname": "Hammersmith Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020416",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60003438",
            "affilname": "ORYGEN Youth Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003438",
            "affiliation-country": "Australia"
        }
    ],
    "funding": [
        "NHMRC"
    ]
}